Neuropathic pain in cats: Mechanisms and multimodal management
ReviewCats
- Design
- Review
- Subjects
- Narrative review with three case vignettes
- Dose used in the study
- Not applicable
- Duration
- Not applicable
- What was measured
- Mechanisms of neuropathic pain in cats and a treatment algorithm for general practitioners, listing palmitoylethanolamide among adjuvant options
What the authors reported
This presents a structured approach to recognising and managing neuropathic pain in cats, drawing on the literature and the author's own experience. Palmitoylethanolamide appears in the keyword list of adjuvant therapies; the abstract gives no evidence grading for it.
Limits of this study
A clinical review by one author, not a trial or systematic review. The abstract says the evidence base is current literature where available plus the author's experience. Listed so readers can see how veterinary reviewers place the compound; it is not evidence of effect in cats. Author declares no conflicts.
Source
PubMed 38710218 · doi:10.1177/1098612X241246518
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.